Standard Biotools (LAB) Other Non-Current Liabilities (2010 - 2026)

Standard Biotools (LAB) has 17 years of Other Non-Current Liabilities data on file, last reported at $4.4 million in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 27.34% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 27.34% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 14.41% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $4.4 million, up from $1.2 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for LAB reached as high as $4.4 million in Q1 2026 and fell as low as $550000.0 in Q1 2023.
• Historically, Other Non-Current Liabilities has averaged $1.6 million across 5 years, with a median of $1.2 million in 2025.
• Across the five-year window, Other Non-Current Liabilities slumped 63.19% in 2023 and soared 412.73% in 2024, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $961000.0 in 2022, then climbed by 10.82% to $1.1 million in 2023, then declined by 0.28% to $1.1 million in 2024, then climbed by 14.41% to $1.2 million in 2025, then surged by 265.76% to $4.4 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $4.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.